We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$2.94B
AUM Growth
+$304M
Cap. Flow
+$71.7M
Cap. Flow %
2.44%
Top 10 Hldgs %
30.8%
Holding
315
New
11
Increased
100
Reduced
87
Closed
13

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$26.2M
2
PFE icon
Pfizer
PFE
+$6.86M
3
HD icon
Home Depot
HD
+$6.66M
4
FRC
First Republic Bank
FRC
+$6.59M
5
V icon
Visa
V
+$5.61M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$18.4M
2
KDP icon
Keurig Dr Pepper
KDP
+$10.8M
3
PPG icon
PPG Industries
PPG
+$6.71M
4
VZ icon
Verizon
VZ
+$4.77M
5
AMZN icon
Amazon
AMZN
+$4.75M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 18.39%
3 Healthcare 13.94%
4 Consumer Discretionary 10.71%
5 Communication Services 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC.V icon
251
McCormick & Company Voting
MKC.V
$13.4B
$295K 0.01%
4,500
ARLP icon
252
Alliance Resource Partners
ARLP
$3.19B
$293K 0.01%
14,365
OXY icon
253
Occidental Petroleum
OXY
$57.3B
$293K 0.01%
3,570
FISV
254
Fiserv Inc
FISV
$26.6B
$288K 0.01%
3,500
CCJ icon
255
Cameco
CCJ
$38.9B
$285K 0.01%
25,020
-800
-3% -$8.41K
UN
256
DELISTED
Unilever NV New York Registry Shares
UN
$283K 0.01%
5,094
BF.B icon
257
Brown-Forman Class B
BF.B
$11.8B
$282K 0.01%
5,587
VBR icon
258
Vanguard Small-Cap Value ETF
VBR
$36.8B
$279K 0.01%
2,000
GSK icon
259
GSK
GSK
$102B
$276K 0.01%
5,501
MSON
260
DELISTED
Misonix Inc
MSON
$270K 0.01%
14,600
TMO icon
261
Thermo Fisher Scientific
TMO
$213B
$267K 0.01%
1,095
VCIT icon
262
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66B
$266K 0.01%
+3,180
New +$266K
CNQ icon
263
Canadian Natural Resources
CNQ
$98B
$261K 0.01%
16,336
NXTM
264
DELISTED
NxStage Medical Inc.
NXTM
$259K 0.01%
9,300
-1,500
-14% -$42.2K
YUM icon
265
Yum! Brands
YUM
$40.6B
$257K 0.01%
2,825
ADM icon
266
Archer Daniels Midland
ADM
$41.6B
$251K 0.01%
5,000
MCRO
267
DELISTED
IQ Hedge Macro Tracker
MCRO
$247K 0.01%
9,400
LBRDK icon
268
Liberty Broadband Class C
LBRDK
$4.26B
$244K 0.01%
+2,894
New +$231K
EWC icon
269
iShares MSCI Canada ETF
EWC
$6.01B
$237K 0.01%
8,220
BP icon
270
BP
BP
$113B
$230K 0.01%
5,217
-75
-1% -$3.14K
MPC icon
271
Marathon Petroleum
MPC
$91.2B
$230K 0.01%
2,870
-500
-15% -$39.5K
TVRD
272
Tvardi Therapeutics
TVRD
$24M
$228K 0.01%
+264
New +$191K
UNH icon
273
UnitedHealth
UNH
$385B
$223K 0.01%
837
TXN icon
274
Texas Instruments
TXN
$259B
$217K 0.01%
2,022
+49
+2% +$5.45K
BKR icon
275
Baker Hughes
BKR
$55.6B
$215K 0.01%
6,368

Similar funds

Rathbones Group's Q3 2018 Portfolio in Review

As of Q3 2018, Rathbones Group held 315 positions worth $2.94B, up 12% from $2.64B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rathbones Group's Q3 2018 filing shows 11 new, 100 increased, 87 reduced and 13 closed positions. Its largest new stake was Idexx Laboratories: 107,900 shares worth $26.9M. The largest sale was Lockheed Martin, an estimated $18.4M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Rathbones Group's largest Q3 2018 buy was Idexx Laboratories: 107,900 shares worth $26.9M.
  • Rathbones Group added most to Pfizer in Q3 2018, an estimated $6.86M increase.
  • Rathbones Group's biggest Q3 2018 reduction was Lockheed Martin, cutting an estimated $18.4M.
  • Rathbones Group fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $10.8M.
  • Rathbones Group's ten largest holdings make up 31% of its $2.94B portfolio in Q3 2018.
  • Rathbones Group opened 11 new positions and closed 13 in Q3 2018.
  • Rathbones Group's portfolio value rose 12% quarter-over-quarter to $2.94B.

Based on Rathbones Group's 13F filing for Q3 2018, filed 12 Oct 2018.